Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Pain management stories

Oct 8, 2026

Viatris to acquire Pacira BioSciences for $1.65 billion

Drugmaker Viatris has agreed to buy pain-drug maker Pacira BioSciences for $1.65 billion in cash, expanding its portfolio of pain management therapies.

Oct 8, 2026·2 sources
00
Sep 17, 2026

Clinical trial finds intrauterine mepivacaine reduces pain during IUD insertion

A placebo-controlled trial demonstrated that intrauterine instillation of the anesthetic mepivacaine effectively reduces pain during intrauterine device (IUD) placement, particularly in nulliparous patients. The findings address growing patient reports of pain during IUD insertion procedures.

Sep 17, 2026·3 sources
00
Jul 29, 2026

Latigo reports positive mid-stage trial results for pain drug competing with Vertex's Journavx

Latigo has announced successful mid-stage clinical trial results for its non-opioid pain medication, positioning it as a potential competitor to Vertex Pharmaceuticals' pain drug Journavx in a field historically marked by development failures.

Jul 29, 2026·1 source
00
Jul 24, 2026

FDA Approves First Over-the-Counter Combination Pill of Tylenol and Naproxen for Pain Relief

The U.S. Food and Drug Administration approved a nonprescription fixed-dose combination pill containing acetaminophen (650 mg) and naproxen sodium (220 mg), marketed as Tylenol with Naproxen by Kenvue. The medication provides up to 12 hours of pain relief for patients aged 12 and older.

Jul 24, 2026·9 sources
00

Top claims

  • ▪Viatris stated that the acquisition of Pacira BioSciences would have a minimal impact on the gross leverage ratio of Viatris
  • ▪Viatris expects the acquisition of Pacira BioSciences to be immediately accretive to the financial guidance metrics of Viatris upon closing
  • ▪Viatris' acquisition price of $36.50 per share represents a premium of approximately 45% to Pacira BioSciences' closing price of $25.20 on October 7, 2026

Subtopics

Drug Approval and Clinical Trials3Drug Policy, Pricing & Approval3Clinical trials2FDA drug approval1Pharma1Pharmaceutical Industry1Women’s health1

Related timelines

Congress

110 stories

Crypto hacks

100 stories

Iran War

209 stories

Payments

118 stories

Russia-Ukraine war

136 stories